300633 logo

SonoScape Medical Corp. Stock Price

SZSE:300633 Community·CN¥8.2b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

300633 Share Price Performance

CN¥19.05
-10.56 (-35.66%)
CN¥19.05
-10.56 (-35.66%)
Price CN¥19.05

300633 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record.

1 Risk
4 Rewards

SonoScape Medical Corp. Key Details

CN¥2.4b

Revenue

CN¥947.0m

Cost of Revenue

CN¥1.4b

Gross Profit

CN¥1.2b

Other Expenses

CN¥177.6m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.41
59.87%
7.53%
7.8%
View Full Analysis

About 300633

Founded
2002
Employees
3133
CEO
Kunxiang Wu
WebsiteView website
www.sonoscape.com

SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. It offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, light sources, gastroenterology and pulmonology products, endoscopic ultrasound, duodenoscopes, and peripheral equipment; minimally invasive surgery solutions, such as camera systems and flexible endoscopes; veterinary ultrasound and endoscopy solutions; and intravascular intervention products. The company also provides face-to-face and online training for ultrasound and endoscopy systems; technical and spare parts support; preventive maintenance, calibration, breakdown repair, and other field services; and upgrade services. In addition, it is involved in the software industry. SonoScape Medical Corp. was incorporated in 2002 and is headquartered in Shenzhen, China.

Recent 300633 News & Updates

Recent updates

No updates